Related Experiment Videos
Modulation of estrogen receptor activity by selective coregulators
Paolo G V Martini1, Benita S Katzenellenbogen
1Department of Molecular and Integrative Physiology, College of Medicine, University of Illinois, 524 Burrill Hall, 407 South Goodwin Avenue, Urbana, IL 61801, USA.
The Journal of Steroid Biochemistry and Molecular Biology
|August 29, 2003
Summary
Researchers discovered a new protein, repressor of estrogen receptor activity (REA), that selectively inhibits estrogen receptor (ER) activity. Prothymosin-alpha (PTalpha) counteracts REA, highlighting their roles in modulating ER specificity.
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Research
Background:
- Estrogen receptor (ER) is a key target in breast cancer therapy.
- ER mediates estrogen and antiestrogen effects in target cells.
- Inactivating ER is a strategy to suppress cancer growth.
Purpose of the Study:
- Identify novel regulators of estrogen receptor (ER) activity.
- Investigate the mechanism of selective ER repression.
- Explore the role of new proteins in modulating nuclear receptor function.
Main Methods:
- Two-hybrid screening to identify interacting proteins.
- Assays to measure transcriptional activity of nuclear receptors.
- Analysis of protein-protein interactions.
Main Results:
- Identified a selective repressor of estrogen receptor activity (REA).
- REA is recruited to the hormone-occupied ER, repressing its activity.
- Prothymosin-alpha (PTalpha) enhances ER activity by displacing REA.
Conclusions:
- REA selectively represses ER transcriptional activity.
- PTalpha enhances ER activity by modulating REA binding.
- REA and PTalpha act as novel modulators conferring ER specificity.